24 KiB
24 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||||
| 4 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.8 | 0 - 6.2 | umol/L | ||||||||||
| 5 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Alkaline Phosphatase | 50 | 40 - 129 | U/L | ||||||||||
| 6 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | ALT (SGPT) | 8 | 5 - 48 | U/L | ||||||||||
| 7 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | AST (SGOT) | 10 | 8 - 40 | U/L | ||||||||||
| 8 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | GGT | 15 | 10 - 61 | U/L | ||||||||||
| 9 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | LDH | 167 | 53 - 234 | U/L | ||||||||||
| 10 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Urea Nitrogen | 4.9 | 1.4 - 8.6 | mmol/L | ||||||||||
| 11 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 91 | 40 - 110 | umol/L | ||||||||||
| 12 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Serum Glucose | 5.7 | R | H | 3.9 - 5.6 | mmol/L | ||||||||
| 13 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Serum Uric Acid | 239 | 125 - 488 | umol/L | ||||||||||
| 14 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Calcium (EDTA) | 2.22 | 2.07 - 2.64 | mmol/L | ||||||||||
| 15 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Phosphorus | 0.91 | 0.71 - 1.65 | mmol/L | ||||||||||
| 16 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Total Protein | 60 | R | L | 61 - 84 | g/L | ||||||||
| 17 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Albumin-BCG | 35 | 33 - 49 | g/L | ||||||||||
| 18 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Creatine Kinase | <18 | R | L | Result verified by repeat analysis | 39 - 308 | U/L | |||||||
| 19 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 20 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Serum Potassium | 3.8 | 3.5 - 5.2 | mmol/L | ||||||||||
| 21 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Serum Bicarbonate | 26.1 | 19.3 - 29.3 | mmol/L | ||||||||||
| 22 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Serum Chloride | 102 | 94 - 112 | mmol/L | ||||||||||
| 23 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CHEMISTRY PANEL | Magnesium | 0.88 | 0.66 - 1.07 | mmol/L | ||||||||||
| 24 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 90 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 25 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | FECAL COLLECTION D/T | Stool Collection Date | Y | 28-May-2026 | |||||||||||
| 26 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:00 | |||||||||||
| 27 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 118 | R | L | 127 - 181 | g/L | ||||||||
| 28 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.37 | R | L | 0.39 - 0.54 | |||||||||
| 29 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.0 | R | L | 4.5 - 6.4 | TI/L | ||||||||
| 30 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 29 | 26 - 34 | pg | ||||||||||
| 31 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 32 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 92 | 79 - 96 | fL | ||||||||||
| 33 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 12.78 | R | H | 3.8 - 10.7 | GI/L | ||||||||
| 34 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 9.55 | R | H | 1.96 - 7.23 | GI/L | ||||||||
| 35 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.58 | 0.91 - 4.28 | GI/L | ||||||||||
| 36 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.46 | 0.12 - 0.92 | GI/L | ||||||||||
| 37 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.12 | 0 - 0.57 | GI/L | ||||||||||
| 38 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||||
| 39 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 74.8 | 40.5 - 75 | % | ||||||||||
| 40 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 20.3 | 15.4 - 48.5 | % | ||||||||||
| 41 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 3.6 | 2.6 - 10.1 | % | ||||||||||
| 42 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.0 | 0 - 6.8 | % | ||||||||||
| 43 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | ||||||||||
| 44 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 371 | 140 - 400 | GI/L | ||||||||||
| 45 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 46 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | LIPID PANEL | Direct HDL-C 4th Generation | 1.18 | 1.03 - 1.53 | mmol/L | ||||||||||
| 47 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | LIPID PANEL | Triglycerides (GPO) | 1.61 | 0.62 - 3.69 | mmol/L | ||||||||||
| 48 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | LIPID PANEL | Cholesterol (High Performance) | 4.55 | 4.19 - 7.24 | mmol/L | ||||||||||
| 49 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | LIPID PANEL | LDL Chol Friedewald 4th | 2.63 | 0 - 3.34 | mmol/L | ||||||||||
| 50 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 51 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 28-May-2026 | |||||||||||
| 52 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 10:45 | |||||||||||
| 53 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 28-May-2026 | |||||||||||
| 54 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 11:53 | |||||||||||
| 55 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 28-May-2026 | |||||||||||
| 56 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 10:45 | |||||||||||
| 57 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 28-May-2026 | |||||||||||
| 58 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 06:00 | |||||||||||
| 59 | CZ100162001 | Male | Induction Week 0 | May 28, 2026 10:45 AM | 6227635174 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 60 | CZ100162002 | Male | Stool Pathogens | May 27, 2026 1:15 PM | 6227635180 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 61 | CZ100162002 | Male | Stool Pathogens | May 27, 2026 1:15 PM | 6227635180 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 62 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||||
| 63 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.7 | 0 - 6.2 | umol/L | ||||||||||
| 64 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Alkaline Phosphatase | 105 | 40 - 129 | U/L | ||||||||||
| 65 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | ALT (SGPT) | 17 | 5 - 48 | U/L | ||||||||||
| 66 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | AST (SGOT) | 18 | 8 - 40 | U/L | ||||||||||
| 67 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | GGT | 14 | 10 - 61 | U/L | ||||||||||
| 68 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | LDH | 194 | 53 - 234 | U/L | ||||||||||
| 69 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Urea Nitrogen | 5.4 | 1.4 - 8.6 | mmol/L | ||||||||||
| 70 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 69 | 40 - 110 | umol/L | ||||||||||
| 71 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Serum Glucose | 5.9 | H | 3.9 - 5.6 | mmol/L | |||||||||
| 72 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Serum Uric Acid | 242 | 125 - 488 | umol/L | ||||||||||
| 73 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Calcium (EDTA) | 2.39 | 2.07 - 2.64 | mmol/L | ||||||||||
| 74 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Phosphorus | 0.82 | 0.71 - 1.65 | mmol/L | ||||||||||
| 75 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Total Protein | 70 | 61 - 84 | g/L | ||||||||||
| 76 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Albumin-BCG | 47 | 33 - 49 | g/L | ||||||||||
| 77 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Creatine Kinase | 67 | 39 - 308 | U/L | ||||||||||
| 78 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 79 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Serum Potassium | 4.7 | 3.5 - 5.2 | mmol/L | ||||||||||
| 80 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Serum Bicarbonate | 23.9 | 19.3 - 29.3 | mmol/L | ||||||||||
| 81 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||||
| 82 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CHEMISTRY PANEL | Magnesium | 0.89 | 0.66 - 1.07 | mmol/L | ||||||||||
| 83 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 117 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 84 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 85 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 140 | 127 - 181 | g/L | ||||||||||
| 86 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.42 | 0.39 - 0.54 | |||||||||||
| 87 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.5 - 6.4 | TI/L | ||||||||||
| 88 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 30 | 26 - 34 | pg | ||||||||||
| 89 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 90 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 91 | 79 - 96 | fL | ||||||||||
| 91 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.92 | 3.8 - 10.7 | GI/L | ||||||||||
| 92 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 5.54 | 1.96 - 7.23 | GI/L | ||||||||||
| 93 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.14 | 0.91 - 4.28 | GI/L | ||||||||||
| 94 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.20 | 0.12 - 0.92 | GI/L | ||||||||||
| 95 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.03 | 0 - 0.57 | GI/L | ||||||||||
| 96 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.02 | 0 - 0.2 | GI/L | ||||||||||
| 97 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 80.1 | H | 40.5 - 75 | % | |||||||||
| 98 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 16.5 | 15.4 - 48.5 | % | ||||||||||
| 99 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 2.8 | 2.6 - 10.1 | % | ||||||||||
| 100 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.4 | 0 - 6.8 | % | ||||||||||
| 101 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.2 | 0 - 2 | % | ||||||||||
| 102 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 363 | 140 - 400 | GI/L | ||||||||||
| 103 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 104 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 105 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 106 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 107 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 108 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 109 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 110 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 111 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 112 | CZ100162002 | Male | Screening | May 27, 2026 12:35 PM | 6227635173 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 113 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | ANATOMICAL SITE | Anatomical Site | Y | 15-20cm from anal verge | |||||||||||
| 114 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 115 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 116 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 19-May-2026 | |||||||||||
| 117 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 09:40 | |||||||||||
| 118 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 119 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 120 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 121 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 12:00 | ||||||||||||
| 122 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 21-May-2026 | ||||||||||||
| 123 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 124 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 125 | CZ100162001 | Male | Biopsy | May 19, 2026 12:00 AM | 6227635193 | ULCERATED AREA | Is biopsy site ulcerated? | Yes | ||||||||||||
| 126 | CZ100162001 | Male | Stool Pathogens | May 6, 2026 9:30 AM | 6228610564 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 127 | CZ100162001 | Male | Stool Pathogens | May 6, 2026 9:30 AM | 6228610564 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 128 | CZ100162001 | Male | Stool Pathogens | Apr 24, 2026 8:45 AM | 6227635182 | C. DIFF EIA | C. diff GDH Ag,stool-CL | |||||||||||||
| 129 | CZ100162001 | Male | Stool Pathogens | Apr 24, 2026 8:45 AM | 6227635182 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | |||||||||||||
| 130 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Total Bilirubin | 10 | 3 - 21 | umol/L | ||||||||||
| 131 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.8 | 0 - 6.2 | umol/L | ||||||||||
| 132 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Alkaline Phosphatase | 60 | 40 - 129 | U/L | ||||||||||
| 133 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | ALT (SGPT) | 11 | 5 - 48 | U/L | ||||||||||
| 134 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | AST (SGOT) | 16 | 8 - 40 | U/L | ||||||||||
| 135 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | GGT | 18 | 10 - 61 | U/L | ||||||||||
| 136 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | LDH | 186 | 53 - 234 | U/L | ||||||||||
| 137 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Urea Nitrogen | 6.8 | 1.4 - 8.6 | mmol/L | ||||||||||
| 138 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 96 | 40 - 110 | umol/L | ||||||||||
| 139 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Serum Glucose | 5.9 | H | 3.9 - 5.6 | mmol/L | |||||||||
| 140 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Serum Uric Acid | 233 | 125 - 488 | umol/L | ||||||||||
| 141 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Calcium (EDTA) | 2.34 | 2.07 - 2.64 | mmol/L | ||||||||||
| 142 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Phosphorus | 0.76 | 0.71 - 1.65 | mmol/L | ||||||||||
| 143 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Total Protein | 69 | 61 - 84 | g/L | ||||||||||
| 144 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Albumin-BCG | 43 | 33 - 49 | g/L | ||||||||||
| 145 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Creatine Kinase | 36 | R | L | 39 - 308 | U/L | ||||||||
| 146 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 147 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||||
| 148 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Serum Bicarbonate | 26.8 | 19.3 - 29.3 | mmol/L | ||||||||||
| 149 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||||
| 150 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CHEMISTRY PANEL | Magnesium | 0.85 | 0.66 - 1.07 | mmol/L | ||||||||||
| 151 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 84 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 152 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | ||||||||||||
| 153 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 154 | 127 - 181 | g/L | ||||||||||
| 154 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.45 | 0.39 - 0.54 | |||||||||||
| 155 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 5.0 | 4.5 - 6.4 | TI/L | ||||||||||
| 156 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 31 | 26 - 34 | pg | ||||||||||
| 157 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 158 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 90 | 79 - 96 | fL | ||||||||||
| 159 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 13.56 | H | 3.8 - 10.7 | GI/L | |||||||||
| 160 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 11.03 | H | 1.96 - 7.23 | GI/L | |||||||||
| 161 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.38 | 0.91 - 4.28 | GI/L | ||||||||||
| 162 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.65 | 0.12 - 0.92 | GI/L | ||||||||||
| 163 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.36 | 0 - 0.57 | GI/L | ||||||||||
| 164 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.14 | 0 - 0.2 | GI/L | ||||||||||
| 165 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 81.3 | H | 40.5 - 75 | % | |||||||||
| 166 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 10.2 | L | 15.4 - 48.5 | % | |||||||||
| 167 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 4.8 | 2.6 - 10.1 | % | ||||||||||
| 168 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 2.7 | 0 - 6.8 | % | ||||||||||
| 169 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | 0 - 2 | % | ||||||||||
| 170 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 233 | 140 - 400 | GI/L | ||||||||||
| 171 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 172 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | |||||||||||
| 173 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 174 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | |||||||||||
| 175 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 176 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 177 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | |||||||||||
| 178 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 179 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | |||||||||||
| 180 | CZ100162001 | Male | Screening | Apr 21, 2026 10:45 AM | 6227635171 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm |